Sundaram Multi. (SUNDARAM)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at a 23% discount to book value (P/B 0.77 vs book value ₹1.86), offering a margin of safety if assets are worth book.
• Low leverage with Debt/Equity of 0.31, giving financial flexibility.
• Sales growth of 22.05% and latest quarter sales of ₹26 Cr show expanding top-line momentum.
• Piotroski F-Score of 6/9 suggests broadly acceptable financial health despite weak profitability.
• Profit growth of 153.90%, though from a small base, indicates improving operations.

Concerns

• Trailing P/E of 95.41 is very expensive; the market is pricing in continued earnings growth from a tiny profit base.
• ROCE is negative at -2.20% and ROE is only 1.27%, meaning capital is not earning its cost.
• Zero dividend yield means no income support; returns depend entirely on speculative capital gains.
• Promoter holding of just 31.11% is low for a microcap and raises governance risk.

AI Analysis

At ₹1.43, Sundaram Multi looks like a classic Graham asset play: the stock trades at 0.77 times book value of ₹1.86, and the balance sheet carries only 0.31 debt-to-equity. But a low price-to-book is only meaningful if the assets can earn a reasonable return. Here, ROE is a meager 1.27% and ROCE is negative at -2.20%. That tells me this is not a wonderful business; it is a marginal one. In stationery, there is little pricing power, no brand moat, and intense competition from organized and unorganized players. The reported sales growth of 22.05% and profit growth of 153.90% look attractive, but they start from a very low profit base. The trailing P/E of 95.41 means the market is already paying a rich price for that improvement. The latest quarter shows sales of ₹26 Cr and net profit of ₹2 Cr; if that run-rate continues, it will change the arithmetic, but one quarter is not enough evidence to call it a durable turnaround. The Piotroski score of 6/9 is passable, and low debt is comforting, but the promoter holding of only 31.11% is not what I like to see in a small cap. I also get zero dividend yield, so all returns must come from capital appreciation. A business earning 1.27% ROE should not trade at 95 times trailing earnings, even if the price is below book. For a patient investor, the real question is whether operational returns can improve materially. Until I see sustained higher ROCE, improved margins, and consistent cash profits, I will not confuse a cheap-looking stock with a cheap business.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer